ARTICLE
5 March 2020

康信知识产权杂志2020年第2期

K
Kangxin

Contributor

Kangxin Partners is a leading Chinese IP firm, providing comprehensive IP services to global and domestic clients for over 25 years. Experienced IP professionals work with clients ranging from startups to Fortune 500 companies to secure their IP assets. Kangxin grows exponentially while continuing to provide exceptional IP services.
本文将利用网络数据库中...
China Intellectual Property

经典案例

2019年专利侵权诉讼案件情况浅析

本文将利用网络数据库中公布的裁判文书数据对2019年由最高院和各地高院判决的专利案件进行统计分析,以对2019年的专利诉讼情况进行初步判断。

【华源原创】关于抗冠状病毒药物 "瑞德西韦"的专利问题一文全解!

本文希望通过简洁的文字将瑞德西韦背后的专利问题集中解答与阐述,帮助读者理清药品和专利之间的关系。

专家说

在家办公 - 知识产权管理未按"暂停"键 吴琼

在家办公如何做好知识产权保护?

【华源原创】新型冠状病毒的可能药物Remdesivir的专利布局? 贾旭 李慧

新型冠状病毒肺炎疫情形势日趋严峻,截至到2020年2月2日,全国感染新冠肺炎人数过万,死亡病例也超出300例。寻找或研制新型冠状病毒的特效药成为当务之...

业界资讯

康信动态

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More